相关实验视频

Updated: Jun 13, 2025

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

简化过敏接触性皮肤炎管理与接触过敏物管理程序2.0的管理

Sarah Kamsiah Zemlok¹, Solbie Choi¹, Amber R Atwater¹

¹Sarah Kamsiah Zemlok is from the University of Connecticut School of Medicine, Farmington. Sarah Kamsiah Zemlok also is from and Dr. Yu is from the Department of Dermatology, Massachusetts General Hospital, Boston. Solbie Choi is from the Albert Einstein College of Medicine, Bronx, New York. Dr. Atwater is from Distinctive Dermatology, Vienna, Virginia, and the Department of Dermatology, George Washington University, Washington, DC. Dr. Reeder is from the Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison. Dr. Adler is from the Department of Dermatology, Keck School of Medicine, Los Angeles, California.

|May 20, 2025

概括

管理过敏性接触性皮肤炎 (ACD) 需要战略性避免过敏原. 接触过敏剂管理计划 (CAMP) 2.0为患者和医生提供了增强的指导,改善了生活质量.

科学领域:

皮肤病学皮肤病学
过敏学过敏学
公共卫生公共卫生

背景情况:

过敏性接触性皮肤炎 (ACD) 给患者带来了重大管理挑战.
有效地避免过敏原是至关重要的,但对于个人来说往往很困难.
医生意识到患者的挑战和长期策略是必不可少的.

研究的目的:

突出接触过敏原数据库在ACD管理中的作用.
引入更新的接触过敏原管理计划 (CAMP) 2.0.0.
展示CAMP 2.0和产品数据库如何优化患者的治疗结果.

主要方法:

对更新的CAMP 2.0功能进行了审查.
讨论利用接触过敏原数据库的策略.
分析这些工具如何支持患者教育和自我管理.

主要成果:

CAMP 2.0为自我和医生指导的指导提供了增强的资源.
产品数据库工具有助于优化ACD患者的治疗结果.
对患有ACD的患者来说,改善生活质量是关键的好处.

结论:

接触过敏原数据库对于患者教育和ACD管理至关重要.
坎普2.0是改善患者生活质量的宝贵资源.
使用像CAMP 2.0这样的更新工具可以提高ACD护理和结果.

更多相关视频

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

相关概念视频

Hypersensitivities

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

Allergic Reactions

Allergic Reactions

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Asthma-IV: Nursing Management

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...